Together, these results demonstrate that the ability of CNNM3 to interact with PRL-2 is essential for tumor progression and that blocking PRL-2·CNNM3 complex formation in vivo causes a growth disadvantage for the tumor cells. The gene discussed is PTP4A2; the disease is neoplasm.